NCT04080323View on ClinicalTrials.gov

Single-dose Vaginal Dinoprostone and Hysterectomy

PHASE3CompletedINTERVENTIONAL
Enrollment

118

Participants

Timeline

Start Date

September 25, 2019

Primary Completion Date

May 30, 2020

Study Completion Date

June 30, 2020

Conditions
Hysterectomy
Interventions
DRUG

Dinoprostone 3 mg

1 vaginal tablet of 3mg dinoprostone 60 minutes before surgery

DRUG

placebo

1 vaginal tablet of placebo 60 minutes before surgery

Trial Locations (1)

11231

Ahmed Samy, Giza

All Listed Sponsors
lead

Cairo University

OTHER

NCT04080323 - Single-dose Vaginal Dinoprostone and Hysterectomy | Biotech Hunter | Biotech Hunter